Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 454

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1B
Chunk 454
---
 (185,367)
  
    Prepaid and Other Assets 
     (39,423) 
     (522,370)
  
    Inventory 
     23,405  
     212,747 
  
    Accounts Payable and Accrued Liabilities 
     501,412  
     (214,734)
  
    Accrued Interest, net 
     (23,604) 
     1,265,361 
  
    Reduction of Lease Liability 
     (13,650) 
     (50,273)
  
    Deferred Compensation 
     -  
     (100,000)
  
    Net Cash Used in Operating Activities 
     (5,648,088) 
     (4,542,910)

    CASH FLOWS FROM INVESTING ACTIVITIES 

    Capitalization of Patents 
     (51,967) 
     (39,982)
  
    Purchases of Fixed Assets 
     (103,773) 
     (57,623)
  
    Acquisition of Intangibles 
     (25,374) 
     (18,283)
  
    Purchase of Short-Term Investments 
     (1,708,000) 
     - 
  
    Net Cash Used in Investing Activities 
     (1,889,114) 
     (115,888)

    CASH FLOWS FROM FINANCING ACTIVITIES 

    Net Proceeds from January 2024 Offering 
     1,898,296  
     - 
  
    Proceeds from IPO and Over-Allotment, net of underwriting discounts, commissions, and deferred offering costs paid in 2023 of $1,198,111 
     -  
     6,303,905 
  
    Proceeds from ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774 
     1,729,810  
     - 
  
    Proceeds from Private Placement, net of offering costs paid at closing and deferred offering costs of $582,600 
     3,414,502  
     - 
  
    Proceeds from Exercise of Warrants 
     -  
     1,131,771 
  
    Proceeds from Exercise of Pre-Funded Warrants 
     10,963  
     - 
  
    Proceed